Neumora Therapeutics is trading 5.02% lower at $0.45, with no confirmed catalyst identified. - No fresh company-specific announcement explaining the October 12, 2026 move was identified; the latest listed company releases predate this session. - Major indices were mixed, and none posted a same-direction move above 0.5%, offering no clear broad-market explanation. - Available evidence points to an unexplained intraday drop; no specific trading-volume information was provided.